SETD2 and neoplasm: SPOP facilitates tumorigenesis by targeting and promoting the degradation of tumor suppressors like LATS1, PTEN, SETD2, and others, thus disrupting important signaling pathways such as the Hippo, PI3K/Akt, and cell cycle regulation pathways.